Sign In
Buy PTCT
$82.13
+1.17 (+1.45%)
At Close: Jun 23, 2026
PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last?
09:21am, Thursday, 18'th Jun 2026
PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price incre
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Wednesday, 17'th Jun 2026
WARREN, N.J., June 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 11, 2026, the company approved non-statutory stock options to purchase an aggregate of 1
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
12:00am, Tuesday, 16'th Jun 2026
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes PR Newswire
PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes
11:14pm, Monday, 15'th Jun 2026
– Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 convertible notes prior to or at maturity – – Offering made at 0% interest with conversion price of $107.48
PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes
07:00am, Monday, 15'th Jun 2026
– Proceeds to be used to repurchase or repay 2026 convertible notes prior to or at maturity – – Offering to include buyback of common stock – WARREN, N.J., June 15, 2026 /PRNewswire/ -- PTC Th
PTC Therapeutics, Inc. (PTCT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
01:12pm, Tuesday, 09'th Jun 2026
PTC Therapeutics, Inc. (PTCT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
PTC Therapeutics, Inc. (PTCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
02:01pm, Tuesday, 12'th May 2026
PTC Therapeutics, Inc. (PTCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
PTC Therapeutics: Sephience Turns The Story From Regulatory Repair To Operating Leverage
11:21pm, Saturday, 09'th May 2026
PTC Therapeutics is transitioning from a legacy rare disease business to a growth-focused model, anchored by the successful Sephience launch. Sephience's rapid commercial uptake is offsetting DMD fran
PTC Therapeutics Q1 Earnings Call Highlights
05:08pm, Friday, 08'th May 2026
PTC Therapeutics NASDAQ: PTCT reported a record first quarter for product revenue and raised its 2026 revenue outlook, citing strong early demand for Sephience, its treatment for phenylketonuria, or P
PTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call Transcript
01:51am, Friday, 08'th May 2026
PTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call Transcript
Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
07:30pm, Thursday, 07'th May 2026
While the top- and bottom-line numbers for PTC Therapeutics (PTCT) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
07:01pm, Thursday, 07'th May 2026
PTC Therapeutics (PTCT) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to earnings of $10.04 per share a year ago.
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
04:01pm, Thursday, 07'th May 2026
– First quarter 2026 total revenue of $273 million, including $226 million of product revenue, supporting full-year 2026 guidance raise – – Global Sephience™ (sepiapterin) launch momentu
Exploring Analyst Estimates for PTC Therapeutics (PTCT) Q1 Earnings, Beyond Revenue and EPS
10:15am, Wednesday, 06'th May 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for PTC Therapeutics (PTCT), delve into some of its key metrics to gain a deeper insight into the company's potential performance fo
PTC Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Monday, 04'th May 2026
WARREN, N.J., May 4, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: Bank of America Securities Health Care Conf
